FDA APPROVED FOR TREATMENT RESISTANT
Major Depressive Disorder
"Please note that transcranial magnetic stimulation (TMS, rTMS) is considered investigational in the USA - except for the cleared intended use for treatment of Major Depression Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.
Depression
The persistent feeling of sadness or loss of interest that characterizes major depression can lead to a range of behavioral and physical symptoms. These may include changes in sleep, appetite, energy level, concentration, daily behavior, or self-esteem. Depression can also be associated with thoughts of suicide.
EXPLORATORY CONDITIONS Also Treated with TMS
"A vast amount of research using rTMS, for other indications than depression, is ongoing. Areas of research include anxiety, bulimia, migraine, pain, rehabilitation of aphasia and motor disability after stroke, tinnitus, Parkinson's disease, and schizophrenia.
Within some of these research areas, clinical trials are taking place."
There is also new promising research to support patients with Autism, OCD, and other neurological conditions. However, mapping to the correct area of the brain is critical for off-label treatment. As we are able to use MRI's to map the precise location of these stimulation points as neurologists pinpoint them, we will be able to increase the spectrum of our treatment to include many of the following conditions.